IL6 and ovarian cancer: Pro-tumorigenic cytokines such as interleukin-6 (IL-6) and interleukin-10 (IL-10) enhance MDSC recruitment and function through activation of the STAT3 signaling pathway, while VEGF and adenosine secreted by ovarian cancer cells further facilitate their accumulation and immune-suppressive effects.